Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Amicus Therapeutics, Inc.January 21, 2021 GMT
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLD
Symposium ™ 2021, to be held virtually February 8-12, 2021.
ADVERTISEMENT
Oral Platform Presentations:
Direct intercellular cross-correction of α-galactosidase-A deficiency in Fabry disease podocytes through tunneling nanotubes in a mixed cell culture model – Behzad Najafian, MD, Department of Pathology, University of Washington, Seattle, WA, USA (Monday, February 8 at 1:12 p.m. EST)